ABLADE

The new €2.3 million Europewide ABLADE (Advanced Bladder cancer LAser Diagnostics and thErapy) project – coordinated by the University of Dundee, working with industrial partners – will study whether advanced laser techniques can be used to both detect and treat the disease. The project will develop integrated laser diagnostic and therapeutic techniques exploiting the different ways cancerous and healthy cells respond to certain IR light. The project brings together experts from the university’s Medical School and Photonics and Nanoscience Group, with SPE Lazma Ltd. in Russia and 2M Netherlands BV. The grant comes from the EU’s Marie Curie IAPP (Industry-Academia Partnership & Pathways) program. The four-year project will see staff seconded between the university and the industry partners, and will create four new research posts.